KPIs & Operating Metrics(New)
Balance Sheet
Cash Flow Statement
Daily Values
Growth Metrics
Income Statement
Others
Ratios
Asset Utilization RatioAssets AverageEBIT MarginEBITDA MarginEBT MarginEnterprise ValueEquity AverageEquity RatioFCF MarginGross MarginInterest Coverage RatioInventory AverageInvested CapitalNet MarginOperating MarginReturn on AssetsReturn on Capital EmployedReturn on EquityReturn on Invested CapitalReturn on SalesTimes Interest Earned

Aurinia Pharmaceuticals (AUPH) Return on Invested Capital (2021 - 2025)

Historic Return on Invested Capital for Aurinia Pharmaceuticals (AUPH) over the last 5 years, with Q3 2025 value amounting to 0.16%.

  • Aurinia Pharmaceuticals' Return on Invested Capital rose 2400.0% to 0.16% in Q3 2025 from the same period last year, while for Sep 2025 it was 0.16%, marking a year-over-year increase of 2400.0%. This contributed to the annual value of 0.01% for FY2024, which is 2000.0% up from last year.
  • Latest data reveals that Aurinia Pharmaceuticals reported Return on Invested Capital of 0.16% as of Q3 2025, which was up 2400.0% from 0.12% recorded in Q2 2025.
  • Aurinia Pharmaceuticals' Return on Invested Capital's 5-year high stood at 0.16% during Q3 2025, with a 5-year trough of 0.6% in Q3 2021.
  • In the last 5 years, Aurinia Pharmaceuticals' Return on Invested Capital had a median value of 0.2% in 2023 and averaged 0.21%.
  • As far as peak fluctuations go, Aurinia Pharmaceuticals' Return on Invested Capital soared by 3300bps in 2022, and later skyrocketed by 500bps in 2024.
  • Quarter analysis of 5 years shows Aurinia Pharmaceuticals' Return on Invested Capital stood at 0.47% in 2021, then soared by 41bps to 0.27% in 2022, then increased by 29bps to 0.2% in 2023, then skyrocketed by 96bps to 0.01% in 2024, then soared by 2164bps to 0.16% in 2025.
  • Its last three reported values are 0.16% in Q3 2025, 0.12% for Q2 2025, and 0.07% during Q1 2025.